DMS Stock Swiss Exchange
Stocks
OXDGM
FR0000063224
Advanced Medical Equipment & Technology
| Market Cap | 28.12M 31.97M 26.12M 24.02M 45.05M 3.1B 45.86M 312M 122M 1.51B 120M 117M 5.24B | P/E 2026 * |
36.2x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 43.52M 49.48M 40.43M 37.18M 69.73M 4.79B 70.98M 483M 189M 2.34B 186M 182M 8.11B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 0.55x |
| Free-Float |
69.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| 06-11 | Oddo BHF Applauds Certification of DMS Group's Onyx Product | |
| 31/05/23 | DMS: Euroland initiates buy coverage | |
| 01/03/19 | DMS : FY18 revenues: uninspiring | AL |
| 08/02/19 | DMS : A new potential deal | AL |
| 14/01/19 | DMS : Some (vague) results on arthritis | AL |
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Sancerni
CEO | Chief Executive Officer | 53 | 18/07/2022 |
Valérie Pugnalon
DFI | Director of Finance/CFO | - | 01/01/2022 |
Swan Tuffery
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Sancerni
CHM | Chairman | 53 | 18/07/2022 |
Julien Delpech
BRD | Director/Board Member | 52 | 16/06/2025 |
| Director/Board Member | - | 24/07/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 32.39M | ||
| +0.01% | +4.45% | -14.78% | -16.59% | 13.79B | ||
| +1.52% | -8.34% | +40.09% | -8.60% | 3.89B | ||
| -0.23% | -4.00% | +64.67% | +106.92% | 1.2B | ||
| -3.05% | -2.34% | -38.13% | -60.52% | 1.21B | ||
| +0.19% | -2.78% | -41.32% | -47.39% | 1.09B | ||
| +0.34% | +2.35% | -42.93% | - | 934M | ||
| +2.37% | -14.11% | +49.28% | +79.71% | 457M | ||
| -4.49% | +3.29% | +55.29% | - | 345M | ||
| -0.21% | +0.88% | -58.49% | +234.80% | 262M | ||
| Average | -0.35% | +1.06% | +1.52% | +41.19% | 2.57B | |
| Weighted average by Cap. | +0.09% | +2.21% | -3.25% | -7.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.8M 64.58M 52.77M 48.53M 91.01M 6.25B 92.64M 631M 246M 3.05B 242M 237M 10.58B | 65.9M 74.93M 61.22M 56.31M 106M 7.26B 107M 732M 286M 3.54B 281M 275M 12.28B |
| Net income | 800K 910K 743K 684K 1.28M 88.09M 1.3M 8.89M 3.47M 42.97M 3.41M 3.34M 149M | 2.6M 2.96M 2.42M 2.22M 4.17M 286M 4.24M 28.88M 11.27M 140M 11.1M 10.86M 484M |
| Net Debt | 15.4M 17.51M 14.31M 13.16M 24.68M 1.7B 25.12M 171M 66.73M 827M 65.74M 64.31M 2.87B | 8M 9.1M 7.43M 6.84M 12.82M 881M 13.05M 88.87M 34.66M 430M 34.15M 33.41M 1.49B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















